United Therapeutics Corp. (UTHR) PT Raised to $175 at Oppenheimer

February 23, 2017 9:27 AM

Oppenheimer raised its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $175.00 (from $160.00) while maintaining a Outperform rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found